Ondine Biomedical Inc. announces the appointment of Kwong Choo as Interim Chief Financial Officer, following the resignation of previous CFO J. P. Errico. Mr. Choo, CPA, CIMA, brings more than15 years of experience in international public companies on NASDAQ, the Toronto Stock Exchange, and the TSX Venture Exchange, as well as with a number of private biotechnology and pharmaceutical companies. Mr. Choo has been working with Ondine since 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 GBX | -7.14% | +26.83% | -25.71% |
05-08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
05-03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.71% | 19.83M | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- OBI Stock
- News Ondine Biomedical Inc.
- Ondine Biomedical Inc. Announces Chief Financial Officer Changes